Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NP2GO vs TeleHealth Med

NP2GO
Graded #37

Higher grade

vs+14.100000000000009
TeleHealth Med
Graded #209

Lower grade

The verdict

NP2GO takes it — 80.2/100 to 66.1/100.

NP2GO grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Both molecules across 40 states, but upper-mid pricing and no verification listing.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNP2GO +7
81
74
Dose & formulationNP2GO +17
80
63
Clinical oversightNP2GO +3
79
76
Labs & monitoringNP2GO +26
78
52
FulfillmentNP2GO +19
82
63
Contract termsNP2GO +27
82
55
NP2GO · left barTeleHealth Med · right bar

The numbers

MetricNP2GOTeleHealth Med
WeighScore80.2/10066.1/100
GradeB−C
Scorecard rank#37#209
Semaglutide$150/mo$147/mo (starting dose, compounded)
Tirzepatide$250/moNot disclosed
Coverage40 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
NP2GO

Graded #37 · B−

Strengths

  • Both molecules
  • 40-state footprint
  • Transparent listed pricing

Where it loses points

  • Not LegitScript-verified
  • Upper-mid pricing ($150/$250)
  • Not all 50 states
TeleHealth Med

Graded #209 · C

Strengths

  • Corporate entity disclosed (TeleHealth Med, Inc.) — clearer accountability than undisclosed competitors
  • Publishes the FDA compounded-medication disclaimer
  • 503A pharmacy designation stated in the FAQ
  • Honest disclosure that testimonials are compensated and results aren't independently verified
  • Both injectable and sublingual forms offered

Where it loses points

  • Specific 503A pharmacy partner not named
  • LegitScript ID number not shown in text — only a verification link
  • Full states-served list not disclosed
  • Named medical director not disclosed
  • Dose tiers beyond the $147/mo starting price not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard